Request Deal Involvement

AyurMaya led a $132m Series C round in Endeavor BioMedicines.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Sam Brown

pr advisors

Sam Brown

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

AYURMAYA CAPITAL

bidder

AYURMAYA CAPITAL

SYMBIOSIS

bidder

SYMBIOSIS

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

VELOCITY CAPITAL ADVISORS LLC

bidder

VELOCITY CAPITAL ADVISORS LLC

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

ABRDN INC

bidder

ABRDN INC

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

ENDEAVOR BIOMEDICINES

target

ENDEAVOR BIOMEDICINES

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

OMEGA FUNDS

bidder

OMEGA FUNDS

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

ECKUITY CAPITAL

bidder

ECKUITY CAPITAL

MATRIX CAPITAL MANAGEMENT

bidder

MATRIX CAPITAL MANAGEMENT

PIPER HEARTLAND HEALTHCARE CAPITAL

bidder

PIPER HEARTLAND HEALTHCARE CAPITAL

SILVER ARCH BIO

bidder

SILVER ARCH BIO

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - AyurMaya led a $132m Series C round in Endeavor BioMedicines.